优化MDT模式在碘131治疗甲亢中的应用研究

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (31 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the application of optimized multidisciplinary diagnosis and treatment (MDT) model in the treatment of hyperthyroidism with iodine 131.Methods One hundred patients with hyperthyroidism treated with iodine 131 who were admitted to Pingxiang People′s Hospital, Jiangxi Province from July 2019 to January 2020 were selected and divided into the control group (50 cases) and the observation group (50 cases) by the random number table method.The control group was given the conventional management model, while the observation group was given the optimized MDT model.The hospitalization time, treatment cost, return visit rate and patient satisfaction were compared between the two groups.Results After intervention, the hospitalization time of the observation group was shorter than that of the control group, and the treatment cost was lower than that of the control group, with statistical differences (P＜0.05).The total satisfaction and return visit rate of the observation group were higher than those of the control group,with statistical differences (P ＜0.05).Conclusion The application of optimized MDT model in patients with hyperthyroidism undergoing iodine 131 therapy significantly shortens the length of hospitalization time, reduces treatment cost, and improves patient satisfaction and return visit rate, indicating good application effect.

Key words： Iodine 131 treatment Hyperthyroidism Optimized multidisciplinary diagnosis and treatment model Hospitalization time Treatment cost Return visit rate

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	HE Li-juan
	HE Zhao
	DENG Na
	CHEN Si-ping
	GONG Yu-ping

Cite this article:

HE Li-juan,HE Zhao,DENG Na, et al. Application study of optimized MDT model in treatment of hyperthyroidism with iodine 131[J]. 中国当代医药, 2021, 28(8): 209-211.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I8/209

[1]	李潇，张洪金，陈宝同.Graves 甲亢患者长期服用抗甲状腺药物后接受碘131治疗的临床效果[J].湖南师范大学学报（医学版），2019，16（2）：114-116.
[2]	徐宗彩，刘观鑫，廖宁.综合护理干预对甲状腺癌术后行131碘治疗患者预后的影响[J].广西医学，2018，40（3）：348-350.
[3]	尹嘉晶，曲伸.甲状腺癌诊治的多学科协作诊疗策略[J].中国实用内科杂志，2019，39（4）：342-346.
[4]	葛均波，徐永健，王辰，等.内科学[M].9版.北京：人民卫生出版社，2018：680-681.
[5]	陈存仁，陈开宁，方团育.以胸痛为首发症状的甲状腺功能亢进症一例[J].海南医学，2016，27（15）：2574.
[6]	冯珏.Graves′甲状腺功能亢进症的正确诊断与规范化治疗[J].临床荟萃，2016，31（3）：233-236.
[7]	袁峰，饶茂华，唐嘉励，等.碘-131治疗分化型甲状腺癌骨转移的临床效果及其影响因素[J].新乡医学院学报，2019，36（6）：551-553.
[8]	赵慧.甲状腺功能亢进症患者服药期间的个体化健康教育效果[J].实用临床医药杂志，2016，20（18）：175-176.
[9]	林伟龙.基于PEST-SWOT模型对肿瘤多学科诊疗模式的分析[J].中国肿瘤，2018，27（12）：893-897.
[10]	胡海涛，田丽娟.某省肿瘤医院多学科协作诊疗模式现状[J].解放军医院管理杂志，2019，26（9）：806-808，823.
[11]	赵刚，张一凡.转诊评估和多学科诊疗模式对老年患者临床治疗效果的影响[J].中华老年多器官疾病杂志，2016，15（2）：118-121.
[12]	李茜，孙燕，胡滨.开展新形式门诊多学科联合诊疗模式的探索[J].中国医院管理，2019，39（1）：35-36.
[13]	马沛，吴玉红.针对性护理干预对甲状腺功能亢进症患者负性情绪及护理工作满意度的影响[J].河南医学研究，2019，28（5）：911-913.
[14]	王芬.奥马哈系统对甲亢患者延续护理干预效果的影响[J].国际护理学杂志，2016，35（13）：1787-1790.
[15]	郑玲玉，覃竞燕，王静，等.随访系统格式化信息发送对提高甲状腺功能亢进症患者治疗依从性的观察[J].中华全科医师杂志，2019，18（3）：261-264.